Collagen-induced arthritis is exacerbated in C-reactive protein-deficient mice

Arthritis and Rheumatism

Volumn 63, Issue 9, 2011, Pages 2641-2650

  Jones, Nicholas R ^a   Pegues, Melissa A ^a   McCrory, Mark A ^a   Kerr, Steven W ^b   Jiang, Huiping ^b   Sellati, Rosemarie ^b   Berger, Valentina ^b   Villalona, Jorge ^b   Parikh, Rajvee ^b   McFarland, Mary ^b   Pantages, Lynn ^b   Madwed, Jeffrey B ^b   Szalai, Alexander J ^a  

^a University of Alabama at Birmingham   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD3 ANTIBODY; COLLAGEN; COLLAGEN ANTIBODY; CYTOKINE; ENDOTOXIN; PICRIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTHRITIS; ARTICLE; ATTENUATION; COLLAGEN INDUCED ARTHRITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EVOKED RESPONSE; GENE OVEREXPRESSION; GENOTYPE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; TRANSGENIC ANIMAL; WILD TYPE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CYTOKINES; DISEASE MODELS, ANIMAL; INFLAMMATION; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; SEVERITY OF ILLNESS INDEX;

EID: 80052330043     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30444     Document Type: Article

References (34)

1. Firestein GS,. Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356-61. (Pubitemid 40852711)
2. Goronzy JJ, Weyand CM,. Developments in the scientific understanding of rheumatoid arthritis. Arthritis Res Ther 2009; 11: 249.
3. Kapetanovic MC, Lindqvist E, Saxne T, Eberhardt K,. Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: prevalence and predictive factors of large joint replacement. Ann Rheum Dis 2008; 67: 1412-6.
4. Newkirk MM, Fournier MJ, Shiroky J,. Rheumatoid factor avidity in patients with rheumatoid arthritis: identification of pathogenic RFs which correlate with disease parameters and with the gal(0) glycoform of IgG. J Clin Immunol 1995; 15: 250-7.
5. Gabay C, Kushner I,. Acute phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54. (Pubitemid 29084777)
6. Szalai AJ,. The antimicrobial activity of C-reactive protein. Microbes Infect 2002; 4: 201-5. (Pubitemid 34183495)
7. Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ES, Kastelein JJ,. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J 2010; 31: 2087-91.
8. Mallya RK, de Beer FC, Berry H, Hamilton ED, Mace BE, Pepys MB,. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol 1982; 9: 224-8. (Pubitemid 12014862)
9. Volakanis JE,. Complement activation by C-reactive protein complexes. Ann N Y Acad Sci 1982; 389: 235-50.
10. Molenaar ET, Voskuyl AE, Familian A, van Mierlo GJ, Dijkmans BA, Hack CE,. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein. Arthritis Rheum 2001; 44: 997-1002. (Pubitemid 32433603)
11. Mold C, Gresham HD, Du Clos TW,. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine FcγRs. J Immunol 2001; 166: 1200-5. (Pubitemid 32060280)
12. Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, Sun PD,. Structural recognition and functional activation of FcγR by innate pentraxins. Nature 2008; 456: 989-92.
13. Vigushin DM, Pepys MB, Hawkins PN,. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 91: 1351-7. (Pubitemid 23127332)
14. Walters MT, Stevenson FK, Goswami R, Smith JL, Cawley MI,. Comparison of serum and synovial fluid concentrations of β2-microglobulin and C-reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis. Ann Rheum Dis 1989; 48: 905-11. (Pubitemid 19280912)
15. Zamani B, Jamali R, Ehteram H,. Synovial fluid adenosine deaminase and high-sensitivity C-reactive protein activity in differentiating monoarthritis. Rheumatol Int 2010. E-pub ahead of print.
16. Matsui T, Kuga Y, Kaneko A, Nishino J, Eto Y, Chiba N, et al. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis 2007; 66: 1221-6. (Pubitemid 47309741)
17. Kushner I, Somerville-Volanakis J,. Studies of synovial and serum C-reactive protein in experimental arthritis in rabbits. Proc Soc Exp Biol Med 1973; 142: 112-4.
18. Phillips NC,. Exacerbation of experimental poly- D -lysine arthritis by C-reactive protein. Agents Actions 1982; 12: 344-7. (Pubitemid 12026818)
19. Jiang S, Xia D, Samols D,. Expression of rabbit C-reactive protein in transgenic mice inhibits development of antigen-induced arthritis. Scand J Rheumatol 2006; 35: 351-5. (Pubitemid 44601067)
20. Ciliberto G, Arcone R, Wagner EF, Ruther U,. Inducible and tissue-specific expression of human C-reactive protein in transgenic mice. EMBO J 1987; 6: 4017-22.
21. Szalai AJ, McCrory MA,. Varied biologic functions of C-reactive protein: lessons learned from transgenic mice. Immunol Res 2002; 26: 279-87. (Pubitemid 35177504)
22. Szalai AJ, Nataf S, Hu XZ, Barnum SR,. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J Immunol 2002; 168: 5792-7. (Pubitemid 34556165)
23. Whitehead AS, Zahedi K, Rits M, Mortensen RF, Lelias JM,. Mouse C-reactive protein: generation of cDNA clones, structural analysis, and induction of mRNA during inflammation. Biochem J 1990; 266: 283-90. (Pubitemid 20069050)
24. Inglis JJ, Simelyte E, McCann FE, Criado G, Williams RO,. Protocol for the induction of arthritis in C57BL/6 mice. Nat Protoc 2008; 3: 612-8. (Pubitemid 351516757)
25. Brand DD, Latham KA, Rosloniec EF,. Collagen-induced arthritis. Nat Protoc 2007; 2: 1269-75. (Pubitemid 46901304)
26. Barck KH, Lee WP, Diehl LJ, Ross J, Gribling P, Zhang Y, et al. Quantification of cortical bone loss and repair for therapeutic evaluation in collagen-induced arthritis, by micro-computed tomography and automated image analysis. Arthritis Rheum 2004; 50: 3377-86. (Pubitemid 39372016)
27. Apostolopoulos J, Hickey MJ, Sharma L, Davenport P, Moussa L, James WG, et al. The cytoplasmic domain of tissue factor in macrophages augments cutaneous delayed-type hypersensitivity. J Leukoc Biol 2008; 83: 902-11. (Pubitemid 351959870)
28. Thompson D, Pepys MB, Wood SP,. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 1999; 7: 169-77. (Pubitemid 29159702)
29. Marnell L, Mold C, Du Clos TW,. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 2005; 117: 104-11. (Pubitemid 41407719)
30. Mold C, Gewurz H, Du Clos TW,. Regulation of complement activation by C-reactive protein. Immunopharmacology 1999; 42: 23-30. (Pubitemid 29322284)
31. 1 mice expressing a human C-reactive protein transgene. Arthritis Rheum 2003; 48: 1602-11. (Pubitemid 36682368)
32. Teupser D, Weber O, Rao TN, Sass K, Thiery J, Fehling HJ,. No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice. J Biol Chem 2011; 286: 6272-9.
33. Hu XZ, Wright TT, Jones NR, Ramos TN, Skibinski GA, McCrory MA, et al. Inhibition of experimental autoimmune encephalomyelitis in human C-reactive protein transgenic mice is FcγRIIB dependent. J. Autoimmune Dis 2010; 2011: 484936.
34. b mice susceptible to collagen-induced arthritis. J Exp Med 1999; 189: 187-94. (Pubitemid 29047038)